NEW YORK, June 3 (Reuters) - Qiagen NV , a maker of genetic testing equipment, said on Sunday it will acquire Digene Corp. for $1.6 billion in cash and stock, to expand into testing for cervical ...
Less than a week after the Federal Trade Commission voiced its opposition, Gaithersburg-based Digene Corp. terminated its agreement to be acquired by Cytyc Corp. The deal would have combined the ...
When federal regulators last week approved Digene Corp.'s cervical cancer test as a primary screening tool for women over 30, they catapulted what had been a follow-up test into direct competition ...
NEW YORK, Jan 12 (Reuters) - Digene Corp's new chief executive officer said on Friday the company could not afford to remain "a one-product company" and would aim to disclose a strategy of moving ...